Explore

Rapid Read Rapid Read
AI Platform Predicts Breast Cancer Risk Through Cellular Response to Pressure

AI Platform Predicts Breast Cancer Risk Through Cellular Response to Pressure

Researchers at City of Hope and the University of California, Berkeley have developed a novel AI platform that predicts breast cancer risk by analyzing how single cells respond to pressure. The mechano-node-pore sensing (mechano-NPS) platform assesses the mechanical properties of breast epithelial cells, providing a 'mechanical age' that correlates with cancer risk. The study found that cells with an older mechanical age indicate a higher risk of breast cancer. This approach could fill a critical gap in risk assessment, especially for women without known genetic predispositions. The platform uses simple, affordable electronics, making it scalable for widespread use.
Trendline Trendline
CREATE Medicines Begins Phase 1/2 Trial of MT-304 for HER2-Positive Tumors

CREATE Medicines Begins Phase 1/2 Trial of MT-304 for HER2-Positive Tumors

CREATE Medicines Begins Phase 1/2 Trial of MT-304 for HER2-Positive Tumors
Trendline Trendline
CREATE Medicines Initiates Phase 1/2 Trial for MT-304 Targeting HER2-Positive Tumors

CREATE Medicines Initiates Phase 1/2 Trial for MT-304 Targeting HER2-Positive Tumors

CREATE Medicines Initiates Phase 1/2 Trial for MT-304 Targeting HER2-Positive Tumors
Trendline Trendline
CatalYm Advances Visugromab into Phase 2/3 Trials for Cancer Cachexia

CatalYm Advances Visugromab into Phase 2/3 Trials for Cancer Cachexia

CatalYm Advances Visugromab into Phase 2/3 Trials for Cancer Cachexia
Rapid Read Rapid Read
Memorial Sloan Kettering Study Reveals Tumor Microenvironment's Role in Cancer Progression

Memorial Sloan Kettering Study Reveals Tumor Microenvironment's Role in Cancer Progression

Researchers at Memorial Sloan Kettering Cancer Center have made significant strides in understanding the early stages of tumor formation in lung tissue. Their study, published in Nature, highlights how mutant cells with KRAS mutations interact with surrounding healthy cells to create a microenvironment conducive to tumor growth. This research challenges the traditional view of cancer as merely the uncontrolled proliferation of mutated cells, emphasizing instead the role of the tumor microenvironment. Using advanced lineage-tracing techniques in mouse models, the study reveals that KRAS-mutant cells initiate a 'neighborhood remodeling' process, involving stromal and immune compartments, to support tumor development. The findings suggest that the tumor microenvironment, including fibroblasts and immune cells, plays a crucial role in cancer progression.
Rapid Read Rapid Read
NIT Rourkela Announces JRF Vacancy for Biotechnology Research

NIT Rourkela Announces JRF Vacancy for Biotechnology Research

The National Institute of Technology (NIT) Rourkela has announced a vacancy for a Junior Research Fellow (JRF) in the field of biotechnology. This position is part of a project focused on developing an in-silico model for targeted drug delivery against viral respiratory disorders. The project, funded by the ANRF in Mechanical Engineering, will be led by Prof. Kishore Singh Patel and is set to last for three years. Candidates with a first-class M.E./M.Tech in Biotechnology or related fields, and who have qualified through national eligibility tests like NET/GATE, are encouraged to apply. The role involves computational fluid dynamics analysis and AI/ML-based modeling, offering a monthly stipend of ₹37,000 for the first two years and ₹42,000 for the third year.
Rapid Read Rapid Read
Hannover Medical School Develops Bioreactor for Efficient Macrophage Production

Hannover Medical School Develops Bioreactor for Efficient Macrophage Production

Researchers at Hannover Medical School (MHH) have developed a new method for producing human immune cells, specifically macrophages, using medium-sized bioreactors. This advancement allows for the efficient production of macrophages from induced pluripotent stem cells (iPS cells), which are reprogrammed somatic cells capable of developing into any cell type. The method, published in Nature Protocols, enables the production of up to 40 million macrophages per week over a ten-week period. Macrophages play a crucial role in the immune system, defending against pathogens and repairing damaged tissue. They are already used in clinical therapies for liver diseases and are being explored for treating infectious diseases, inflammation, fibrosis, cancer, and neurodegenerative diseases like Alzheimer's. The new bioreactors are efficient, cost-effective, and easy to handle, making them suitable for preclinical research projects.
Rapid Read Rapid Read
New Sulfur Polymer Shows Promise in Combating Antimicrobial Resistance

New Sulfur Polymer Shows Promise in Combating Antimicrobial Resistance

Researchers at Flinders University, in collaboration with UK experts, have developed a sulfur-rich polymer with potent antimicrobial and antifungal properties. This new material, which does not harm human or plant cells, offers a promising solution to the growing issue of antimicrobial resistance. The polymer is effective against various pathogens, including Staphylococcus aureus and Klebsiella pneumoniae. The research, published in Chemical Science, highlights the potential for this polymer to be used in medicine and agriculture, providing a low-cost and effective alternative to current treatments.
Rapid Read Rapid Read
AI Model Enhances Prediction of Lung Cancer Immunotherapy Outcomes

AI Model Enhances Prediction of Lung Cancer Immunotherapy Outcomes

A new AI model, presented at the American Association for Cancer Research (AACR) Annual Meeting, has shown promise in predicting outcomes and responses to immunotherapy in patients with metastatic non-small cell lung cancer (NSCLC). Developed by researchers at The University of Texas MD Anderson Cancer Center, the model, known as Pathology-driven Immunotherapy Optimization (Path-IO), uses deep learning to analyze digital pathology images. It stratifies patients into higher and lower risk groups, potentially improving patient selection for immunotherapy. The model was validated across international cohorts and a Phase III clinical trial, outperforming the current standard-of-care biomarker, PD-L1, in predicting patient outcomes.
Trendline Trendline
Pfizer Presents Oncology Innovations at ASCO 2026, Highlighting New Cancer Treatment Strategies

Pfizer Presents Oncology Innovations at ASCO 2026, Highlighting New Cancer Treatment Strategies

Pfizer Presents Oncology Innovations at ASCO 2026, Highlighting New Cancer Treatment Strategies
Rapid Read Rapid Read
Tempest Therapeutics Achieves Milestone in CAR-T Therapy Development for Multiple Myeloma

Tempest Therapeutics Achieves Milestone in CAR-T Therapy Development for Multiple Myeloma

Tempest Therapeutics has reached a significant milestone in the development of its TPST-2003 CAR-T therapy for relapsed/refractory multiple myeloma. The company has delivered the TPST-2003 lentiviral vector to Cincinnati Children’s Applied Gene and Cell Therapy Center, enabling the manufacturing activities necessary for a pivotal study. This follows positive interim data from the REDEEM-1 Phase 1/2a trial, where all six evaluable patients achieved a complete response. Tempest plans to initiate a potentially registrational study later this year.
Rapid Read Rapid Read
Memorial Sloan Kettering Cancer Center Reveals Tumor Microenvironment's Role in Cancer Progression

Memorial Sloan Kettering Cancer Center Reveals Tumor Microenvironment's Role in Cancer Progression

Researchers at Memorial Sloan Kettering Cancer Center have unveiled new insights into the early stages of tumor formation in lung tissue. The study, published in Nature, highlights the interactions between mutant cells and their healthy neighbors, emphasizing the tumor microenvironment as a crucial element in cancer progression. Using lineage-tracing techniques in mouse models mimicking human lung adenocarcinoma, the team discovered that KRAS-mutant cells orchestrate a 'neighborhood remodeling' process involving stromal and immune compartments. This process creates a fibrotic niche that supports tumor growth and influences the immune landscape, promoting immunosuppressive macrophages and regulatory immune cells. The study suggests that disrupting this pathogenic communication can halt tumor progression, offering potential for early therapeutic intervention.